SCHEMBL8974334

SCHEMBL8974334

Cc1ccc(C2=CCC=C2c2ccc(S(N)(=O)=O)nc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 9/20 0.44
CA2 P00918 9/20 0.44
CA9 Q16790 9/20 0.44
CA12 O43570 6/20 0.44
CA5A P35218 6/20 0.44
CA4 P22748 5/20 0.44
CA6 P23280 3/20 0.44
CA7 P43166 3/20 0.44
CA13 Q8N1Q1 2/20 0.44
CA14 Q9ULX7 2/20 0.44
PTGS2 P35354 7/20 0.37
CA5B Q9Y2D0 4/20 0.37
CA3 P07451 1/20 0.37
HSP90AA1 P07900 1/20 0.35
CXCR5 P32302 1/20 0.35
APLNR P35414 1/20 0.35
RAB9A P51151 1/20 0.35
CCR6 P51684 1/20 0.35
GFER P55789 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8973795 0.87 CA1 (0.45) CA1CA2CA9CA12CA5A
SCHEMBL8974374 0.87 PIK3CD (0.39) PTGS2HSP90AA1CXCR5APLNRRAB9A
SCHEMBL8973749 0.85 CA1 (0.44) CA1CA2CA9CA12CA5A
SCHEMBL8974338 0.85 CA1 (0.44) CA1CA2CA9CA12CA5A
SCHEMBL8974062 0.82 KIF11 (0.45) CA1CA2CA9CA12CA5A
SCHEMBL8974661 0.82 CA1 (0.45) CA1CA2CA9CA12CA5A
SCHEMBL9119841 0.82 PTGS2 (0.42) CA1CA2CA9CA12CA5A
SCHEMBL9118877 0.80 CA1 (0.39) CA1CA2CA9CA12CA5A
SCHEMBL9117114 0.80 CA1 (0.39) CA1CA2CA9CA12CA5A
SCHEMBL8974305 0.78 CA2 (0.64) CA1CA2CA9CA12CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995030656-A1 SUBSTITUTED CYCLOPENTADIENYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-11-16 WO claimed
US-5576339-A Pyridyl substituted cyclopentadienes for the treatment of inflamation HUANG HORNG-CHIH (US) 1996-11-19 US disclosed
US-5418254-A Side effect reduction G. D. SEARLE & CO. (US) 1995-05-23 US disclosed